Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the

... Read more

Progenics Pharmaceuticals

... Read more

ProMetic Reports its 2013 Fourth Quarter and Financial Year End Results and

... Read more

Proofpoint Announces

... Read more

Protalix BioTherapeutics Receives Confirmation of Order for over $24 Million of

... Read more

Psychemedics Corporation Announces Record Revenues And

... Read more

Psychemedics Corporation Announces Record Revenues and

... Read more

PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides

... Read more

Denis Corin, President and CEO of Q BioMed Inc. (OTCQB: QBIO) Talks to Daniel Levine of the Bio Report

Pharma Bro, Price Controls, and the Quest to

... Read more

QHR Delivers Growth with Record Revenue of $6.8 Million and EBITDA of $0.9 Million for Q1 2014

... Read more